ADME and pharmacokinetic properties of remdesivir: its drug interaction potential

S Deb, AA Reeves, R Hopefl, R Bejusca - Pharmaceuticals, 2021 - mdpi.com
On 11 March 2020, the World Health Organization (WHO) classified the Coronavirus
Disease 2019 (COVID-19) as a global pandemic, which tested healthcare systems …

Non-P450 drug-metabolizing enzymes: contribution to drug disposition, toxicity, and development

T Fukami, T Yokoi, M Nakajima - Annual Review of …, 2022 - annualreviews.org
Most clinically used drugs are metabolized in the body via oxidation, reduction, or hydrolysis
reactions, which are considered phase I reactions. Cytochrome P450 (P450) enzymes …

[HTML][HTML] Potential herb‒drug interactions between anti-COVID-19 drugs and traditional Chinese medicine

L Ye, S Fan, P Zhao, C Wu, M Liu, S Hu, P Wang… - … Pharmaceutica Sinica B, 2023 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has spread worldwide. Effective treatments against …

Prediction of carboxylesterase 1-mediated in vivo drug interaction between methylphenidate and cannabinoids using static and physiologically based …

Y Qian, JS Markowitz - Drug Metabolism and Disposition, 2022 - ASPET
The use of cannabis products has increased substantially. Cannabis products have been
perceived and investigated as potential treatments for attention-deficit/hyperactivity disorder …

Discovery and Characterization of the Biflavones From Ginkgo biloba as Highly Specific and Potent Inhibitors Against Human Carboxylesterase 2

YQ Song, RJ He, D Pu, XQ Guan, JH Shi… - Frontiers in …, 2021 - frontiersin.org
Human carboxylesterase 2 (CES2), one of the most abundant hydrolases distributed in the
small intestine, has been validated as a key therapeutic target to ameliorate the intestinal …

Hormetic effects of EGC and EGCG on CES1 activity and its rescue from oxidative stress in rat liver S9

X Luo, F Lu, Z Yin, Z Zhou, Z Wang, H Zhang - Chemico-Biological …, 2023 - Elsevier
Abstract Carboxylesterase 1 (CES1) is a hydrolytic enzyme that plays an important role in
the activation or deactivation of many therapeutic agents, thus affecting their …

[HTML][HTML] The influence of cannabidiol on the pharmacokinetics of methylphenidate in healthy subjects

JS Markowitz, L De Faria, Q Zhang… - Medical Cannabis and …, 2022 - karger.com
Introduction: Cannabidiol (CBD) is a widely utilized nonpsychoactive cannabinoid available
as an over-the-counter supplement, a component of medical cannabis, and a prescriptive …

In vitro inhibition of carboxylesterase 1 by Kava (Piper methysticum) Kavalactones

PW Melchert, Y Qian, Q Zhang, BO Klee, C Xing… - Chemico-biological …, 2022 - Elsevier
Kava refers to the extracts from the rhizome of the plant Piper methysticum which is of
particular significance to various indigenous cultures in the South Pacific region …

Natural products: Experimental approaches to elucidate disposition mechanisms and predict pharmacokinetic drug interactions

MF Paine - Drug Metabolism and Disposition, 2020 - ASPET
Natural products have been used by humans since antiquity for both egregious and
beneficial purposes. Regarding the latter, these products have long been valued as a rich …

Regulation of carboxylesterases and its impact on pharmacokinetics and pharmacodynamics: an up-to-date review

Y Liu, J Li, HJ Zhu - Expert Opinion on Drug Metabolism & …, 2024 - Taylor & Francis
ABSTRACT Introduction Carboxylesterase 1 (CES1) and carboxylesterase 2 (CES2) are
among the most abundant hydrolases in humans, catalyzing the metabolism of numerous …